TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NAGE

Niagen Bioscience, Inc.

Healthcare · Biotechnology · —

3.00$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Niagen Bioscience, Inc. (NAGE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 106 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NAGE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12 19 20 63 42 40 38 58 54 55 68 106
9.9 17 16 57 37 34 32 49 47 50 64 97
4.0 5.5 1.6 45 22 19 16 28 20 27 45 65
4.0 5.5 1.6 45 22 19 16 28 20 27 45 65
1.9 2.5 5.9 5.3 4.4 2.2 2.7 5.2 8.5 5.2 7.8 9.7
3.7 8.2 7.9 5.8 8.2 12 12 14 15 15 9.2 20
0.3 0.4 0.5 1.7 1.5 1.3 1.1 0.9 0.7 0.5 0.4 5.7
7.5 13 9.8 8.9 15 20 22 26 25 27 22 30
5.0 9.6 8.9 8.1 14 15 16 18 18 21 18 20
0.4 1.7 0.3 0.2 0.2 0.9 0.6 0.5 0.7 0.7 1.0 1.0
3.5 6.2 6.0 3.7 9.5 9.6 9.4 10 9.7 10 8.5 11
4.0 5.3 10.0 54 27 20 16 32 29 28 46 77
-40 -42 -45 -57 -90 -122 -142 -169 -185 -190 -182 -165
35 36 37 45 55 57 61 67 70 75 80 85

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?